Name | Remimazolam |
---|---|
Synonyms |
methyl (S)-3-(8-bromo-1-methyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,2-a][1,4]diazepin-4-yl)propanoate
methyl 3-[(4S)-8-bromo-1-methyl-6-pyridin-2-yl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoate IMI030 CNS 7056 CN-7056 |
Description | Remimazolam (CNS-7056) is a short-acting GABA(A) receptor agonist[1]. |
---|---|
Related Catalog | |
Target |
GABA(A) receptor[1] |
References |
Molecular Formula | C21H19BrN4O2 |
---|---|
Molecular Weight | 439.30500 |
Exact Mass | 438.06900 |
PSA | 69.37000 |
LogP | 3.61910 |
Storage condition | 2-8℃ |
~88% 308242-62-8 |
Literature: CeNes Limited Patent: EP1183243 B1, 2006 ; Location in patent: Page/Page column 36; 37 ; |
~73% 308242-62-8 |
Literature: PAION UK Limited Patent: EP2305647 A1, 2011 ; Location in patent: Page/Page column 11 ; |
~% 308242-62-8 |
Literature: PAION UK Limited Patent: EP2305647 A1, 2011 ; Location in patent: Page/Page column 11-12 ; |
~% 308242-62-8 |
Literature: PAION UK Limited Patent: EP2305647 A1, 2011 ; |
~% 308242-62-8 |
Literature: PAION UK Limited Patent: EP2305647 A1, 2011 ; |
~% 308242-62-8 |
Literature: PAION UK Limited Patent: EP2305647 A1, 2011 ; |
~% 308242-62-8 |
Literature: PAION UK Limited Patent: EP2305647 A1, 2011 ; |
~% 308242-62-8 |
Literature: PAION UK Limited Patent: EP2305647 A1, 2011 ; |
~% 308242-62-8 |
Literature: PAION UK Limited Patent: EP2305647 A1, 2011 ; |
Precursor 6 | |
---|---|
DownStream 0 |